FDA Approves Lumithera’s Photobiomodulation Device for Dry AMD
Lumithera’s Valeda becomes the first FDA-approved treatment for vision loss caused by dry AMD Dry AMD sufferers in the United…
Espansione Group’s eye-light® Expands Its Horizons: New CE (MDR) Mark for Corneal and Retinal Care
Espansione Group (Zona Artigianale Funo BO, Italy), a leader in medtech innovation in ophthalmology, announced today a major milestone for…
popular posts
latest posts
